Clinical trials
Terminated Ovarian Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 2 |
| Akeso | 1 |
| Aravive, Inc. | 1 |
| AstraZeneca | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| First Affiliated Hospital of Harbin Medical University | 1 |
| Genmab | 1 |
| Haihe Biopharma Co., Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| Peking Union Medical College Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 13 |
| Carcinoma, Ovarian Epithelial | 2 |
| Endometrial Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Transitional Cell | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.